Arcturus Therapeutics: A Speculative Buy For Their OTC Deficiency Program
C. C. Abbott NASDAQ
Arcturus Therapeutics Holdings Inc.
ARCT
1 story
$481M Market cap · 2026-09-18
C. C. Abbott C. C. Abbott 
NASDAQ
ARCT
1 story
$481M Market cap · 2026-09-18